Owners
Crospon founded in 2006 is located in the Irish city of Galway and has representations in California. The company specializes in release of the endoscopic equipment for diagnostics and treatment of gastrointestinal diseases. Among products — the diagnostic Endoflip system intended for assessment of the main violations of motility.
In 2016 in staff of Crospon there were 16 people, including the employees occupied with researches and operating activities and also a marketing and managerial personnel.
Performance Indicators
2016
In 2016 Crospon registered a loss in the amount of more than 535 thousand euros, and total losses of the company reached nearly 13 million euros. Crospon does not publish data on sales, but, according to excerpts from the reduced reporting, in 2016 revenue of the company increased by 8%. According to forecasts, in 2017 growth by 30% is expected.
History
2017: Medtronic buys Crospon
At the beginning of December, 2017 it became known merger of the Irish producer of the Crospon iatrotechnics by the American company Medtronic.
On December 8, 2017 announced the first the news edition FORA purchase. According to its information, transaction amount was $45 million or 38 million euros. Medtronic confirmed acquisition, but did not open how much purchase cost.
This transaction expands the range of our solutions for maintaining patients with gastrointestinal frustration. With purchase of Crospon in a product portfolio of Medtronic the leading solutions for diagnostics and treatment of diseases of a gullet will appear — the press secretary of the company said. |
The head of Crospon John O'Dea announced (John O’Dea) sale to the company, having made the corresponding record on the page in professional social network LinkedIn. According to O'Dea, in the company are very glad to appear under a wing of one of world leaders in the field of the gastrodiagnostiki on behalf of Medtronic.[1]